The Acid Sphingomyelinase Inhibitor Amitriptyline Ameliorates TNF-α-induced Endothelial Dysfunction via the MAPK Signaling Pathway

Yang Ji(Second Affiliated Hospital of Guangzhou Medical University), Yun Zhong(State Key Laboratory of Respiratory Disease)

Research Square

March 31, 2022

10.21203/rs.3.rs-1493965/v1

Cited by 2

Related Papers

The Acid Sphingomyelinase Inhibitor Amitriptyline Ameliorates TNF-α-Induced Endothelial Dysfunction

|Cardiovascular Drugs and Therapy|2022|26

AGE induced macrophage-derived exosomes induce endothelial dysfunction in diabetes via miR-22-5p/FOXP1

|Cardiovascular Diabetology|2025|11